336 related articles for article (PubMed ID: 28960268)
41. Frequency, pattern, and extent of skin diseases in relation to CD4+ cell count among adults with human immunodeficiency virus infection or acquired immunodeficiency syndrome in Osogbo, southwestern Nigeria.
Akinboro AO; Onayemi O; Mejiuni AD
Int J Dermatol; 2014 Apr; 53(4):416-24. PubMed ID: 24783258
[TBL] [Abstract][Full Text] [Related]
42. Epidemiological and Clinical Patterns of Kaposi Sarcoma: A 16-Year Retrospective Cross-Sectional Study from Yaoundé, Cameroon.
Tounouga DN; Kouotou EA; Nansseu JR; Zoung-Kanyi Bissek AC
Dermatology; 2018; 234(5-6):198-204. PubMed ID: 30205412
[TBL] [Abstract][Full Text] [Related]
43. [CD4+ lymphocytes and opportunistic infections and neoplasms in patients with human immunodeficiency virus infection].
Miró JM; Buira E; Mallolas J; Gallart T; Moreno A; Zamora L; Vilella R; Gatell JM; Soriano E
Med Clin (Barc); 1994 Apr; 102(15):566-70. PubMed ID: 7646597
[TBL] [Abstract][Full Text] [Related]
44. Cutaneous manifestations of human immunodeficiency virus in Lusaka, Zambia.
Hira SK; Wadhawan D; Kamanga J; Kavindele D; Macuacua R; Patil PS; Ansary MA; Macher AM; Perine PL
J Am Acad Dermatol; 1988 Sep; 19(3):451-7. PubMed ID: 2971691
[TBL] [Abstract][Full Text] [Related]
45. Sensitivity, specificity, and positive predictive value of oral opportunistic infections in adults with HIV/AIDS as markers of immune suppression and viral burden.
Patton LL
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2000 Aug; 90(2):182-8. PubMed ID: 10936837
[TBL] [Abstract][Full Text] [Related]
46. Dermatological lesions among people living with HIV in Turkey.
Mustafayev K; Mete B; Kutlubay Z; Tanakol A; Şahin Özdemir M; Garashova D; Balkan İİ; Saltoglu N; Tabak ÖF
Int J STD AIDS; 2022 Jan; 33(1):55-62. PubMed ID: 34565234
[TBL] [Abstract][Full Text] [Related]
47. Mucocutaneous manifestation of pediatric human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) in relation to degree of immunosuppression: a study of a West African population.
Umoru D; Oviawe O; Ibadin M; Onunu A; Esene H
Int J Dermatol; 2012 Mar; 51(3):305-12. PubMed ID: 22348567
[TBL] [Abstract][Full Text] [Related]
48. Oral lesions in HIV/AIDS patients undergoing highly active antiretroviral treatment including protease inhibitors: a new face of oral AIDS?
Ceballos-Salobreña A; Gaitán-Cepeda LA; Ceballos-Garcia L; Lezama-Del Valle D
AIDS Patient Care STDS; 2000 Dec; 14(12):627-35. PubMed ID: 11119429
[TBL] [Abstract][Full Text] [Related]
49. Dermatologic manifestations of HIV infection.
Maurer TA
Top HIV Med; 2005 Dec-2006 Jan; 13(5):149-54. PubMed ID: 16377853
[TBL] [Abstract][Full Text] [Related]
50. Oral manifestations associated with HIV-related disease as markers for immune suppression and AIDS.
Glick M; Muzyka BC; Lurie D; Salkin LM
Oral Surg Oral Med Oral Pathol; 1994 Apr; 77(4):344-9. PubMed ID: 8015797
[TBL] [Abstract][Full Text] [Related]
51. The spectrum of mucocutaneous manifestations during the evolutionary phases of HIV disease: an emerging Indian scenario.
Singh A; Thappa DM; Hamide A
J Dermatol; 1999 May; 26(5):294-304. PubMed ID: 10380430
[TBL] [Abstract][Full Text] [Related]
52. Mucocutaneous manifestations in Indian children with human immunodeficiency virus infection.
Mittal S; Mendiratta V; Kumar P; Chander R
Pediatr Dermatol; 2013; 30(6):e274-5. PubMed ID: 23758083
[TBL] [Abstract][Full Text] [Related]
53. Dynamics of T-cell subsets and their relationship with oral and systemic opportunistic infections in HIV/AIDS patients during the first year of HAART in Guangxi, China.
Zhang L; Huang Y; Liu Z; Liu W; Qin Q; Tao R
J Med Virol; 2015 Jul; 87(7):1158-67. PubMed ID: 25777553
[TBL] [Abstract][Full Text] [Related]
54. Cutaneous findings in HIV-1-positive patients: a 42-month prospective study. Military Medical Consortium for the Advancement of Retroviral Research (MMCARR).
Smith KJ; Skelton HG; Yeager J; Ledsky R; McCarthy W; Baxter D; Turiansky GW; Wagner KF; Turianski G
J Am Acad Dermatol; 1994 Nov; 31(5 Pt 1):746-54. PubMed ID: 7929920
[TBL] [Abstract][Full Text] [Related]
55. Knowledge, attitudes and practices of oral health care workers in Lesotho regarding the management of patients with oral manifestations of HIV/AIDS.
Ramphoma KJ; Naidoo S
SADJ; 2014 Nov; 69(10):446, 448-53. PubMed ID: 26506796
[TBL] [Abstract][Full Text] [Related]
56. The effects of human herpesvirus 8 infection and interferon-gamma response in cutaneous lesions of Kaposi sarcoma differ among human immunodeficiency virus-infected and uninfected individuals.
Guedes F; de Andrade HF; Fernandes ER; Tuon FF; Brasil RA; Pagliari C; Duarte MI
Br J Dermatol; 2008 Sep; 159(4):839-46. PubMed ID: 18644020
[TBL] [Abstract][Full Text] [Related]
57. Kaposi's sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART/chemotherapy in HIV clade C-infected individuals with Kaposi's sarcoma.
Bihl F; Mosam A; Henry LN; Chisholm JV; Dollard S; Gumbi P; Cassol E; Page T; Mueller N; Kiepiela P; Martin JN; Coovadia HM; Scadden DT; Brander C
AIDS; 2007 Jun; 21(10):1245-52. PubMed ID: 17545700
[TBL] [Abstract][Full Text] [Related]
58. Oral manifestations of human immunodeficiency virus-infected patients in Taiwan.
Chiang CP; Chueh LH; Lin SK; Chen MY
J Formos Med Assoc; 1998 Sep; 97(9):600-5. PubMed ID: 9795527
[TBL] [Abstract][Full Text] [Related]
59. [AIDS-associated Kaposi's sarcoma: 22 cases].
Dhrif AS; Kilani B; Ammari L; Kanoun F; Tiouri H; Ben Chaaben T
Tunis Med; 2007 Jun; 85(6):494-9. PubMed ID: 17644904
[TBL] [Abstract][Full Text] [Related]
60. Epidemic (human immunodeficiency virus-related) Kaposi's sarcoma in West African women.
Nnoruka EN
Int J Dermatol; 2003 Oct; 42(10):794-9. PubMed ID: 14521692
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
